Share This Author
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- S. Wiviott, I. Raz, M. Sabatine
- MedicineThe New England journal of medicine
- 24 January 2019
TLDR
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
- B. Scirica, Deepak L. Bhatt, I. Raz
- MedicineThe New England journal of medicine
- 2 October 2013
TLDR
A controlled trial of renal denervation for resistant hypertension.
- Deepak L. Bhatt, D. Kandzari, G. Bakris
- MedicineThe New England journal of medicine
- 9 April 2014
TLDR
Rivaroxaban in patients with a recent acute coronary syndrome.
- J. Mega, E. Braunwald, C. Gibson
- MedicineThe New England journal of medicine
- 4 January 2012
TLDR
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
- J. Collet, H. Thiele, G. Siontis
- Medicine, PsychologyEuropean heart journal
- 29 August 2020
TLDR
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- Deepak L. Bhatt, P. Steg, C. Ballantyne
- MedicineThe New England journal of medicine
- 3 January 2019
TLDR
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- Thomas A. Zelniker, S. Wiviott, M. Sabatine
- Medicine, BiologyThe Lancet
- 5 January 2019
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.
- P. Schauer, Deepak L. Bhatt, S. Kashyap
- MedicineThe New England journal of medicine
- 21 May 2014
TLDR
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.
- L. Bonello, U. Tantry, P. Gurbel
- Medicine, BiologyJournal of the American College of Cardiology
- 14 September 2010
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
- Deepak L. Bhatt, K. Fox, E. Topol
- Medicine, BiologyThe New England journal of medicine
- 20 April 2006
TLDR
...
...